A human proof-of-concept trial of TS-01 in patients with myocardial infarction
Phase of Trial: Phase II
Latest Information Update: 30 Oct 2019
Price : $35 *
At a glance
- Drugs TS 01 (Primary)
- Indications Myocardial infarction
- Focus Proof of concept; Therapeutic Use
- 30 Oct 2019 According to a Thrombolytic Science International media release, protocol has been finalized for this study.
- 06 Sep 2018 According to a Thrombolytic Science media release, the company is planning to initiate this study in 2019.
- 30 May 2018 New trial record